TTM
$0.00
YoY change
—
5Y CAGR
-100.0%
Peak year (2014)
$9.32M
Cumulative revenue
$24.34M
Revenue history chart for SELLAS Life Sciences Group (SLS) from 2006 to 2025
Latest: $0.00
Revenue growth chart for SELLAS Life Sciences Group (SLS) from 2006 to 2025
Latest: -100.0%
Revenue history table for SELLAS Life Sciences Group (SLS) from 2006 to 2025
| 2025 | $0.00 | — | $0.00 | ||
| 2024 | $0.00 | — | $0.00 | ||
| 2023 | $0.00 | -100.0% | −$1.00M | ||
| 2022 | $1.00M | -86.8% | −$6.60M | ||
| 2021 | $7.60M | +300.0% | +$5.70M | ||
| 2020 | $1.90M | — | +$1.90M | ||
| 2019 | $0.00 | — | $0.00 | ||
| 2018 | $0.00 | — | $0.00 | ||
| 2017 | $0.00 | — | $0.00 | ||
| 2016 | $0.00 | — | $0.00 | ||
| 2015 | $0.00 | -100.0% | −$9.32M | ||
| 2014 | $9.32M | +274.7% | +$6.83M | ||
| 2013 | $2.49M | +22.0% | +$449.00K | ||
| 2012 | $2.04M | — | +$2.04M | ||
| 2011 | $0.00 | — | $0.00 | ||
| 2010 | $0.00 | — | $0.00 | ||
| 2009 | $0.00 | — | $0.00 | ||
| 2008 | $0.00 | — | $0.00 | ||
| 2007 | $0.00 | — | $0.00 | ||
| 2006 | $0.00 | — | — |
- 2025$0.00—
- 2024$0.00—
- 2023$0.00-100.0%
- 2022$1.00M-86.8%
- 2021$7.60M+300.0%
- 2020$1.90M—
- 2019$0.00—
- 2018$0.00—
- 2017$0.00—
- 2016$0.00—
- 2015$0.00-100.0%
- 2014$9.32M+274.7%
- 2013$2.49M+22.0%
- 2012$2.04M—
- 2011$0.00—
- 2010$0.00—
- 2009$0.00—
- 2008$0.00—
- 2007$0.00—
- 2006$0.00—
Revenue values are taken from SELLAS Life Sciences Group's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at SELLAS Life Sciences Group (SLS)
According to SELLAS Life Sciences Group's latest reported financial statements, the company's current revenue (TTM) is $0.00. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of SELLAS Life Sciences Group (SLS) revenue is $0.00.
Over 2020–2025 (5 years), SELLAS Life Sciences Group revenue expanded at a -100.0% compound annual rate, with a net decline across the window.
SELLAS Life Sciences Group revenue plunged from $9.32M in 2014 to $0.00 in 2025, a 100.0% drawdown.
The highest annual revenue of $9.32M was reported in 2014. The lowest in the available history was $0.00 in 2006.
SELLAS Life Sciences Group Revenue by Year
SELLAS Life Sciences Group Revenue 2025: $0.00
SELLAS Life Sciences Group revenue in 2025 was $0.00.
SELLAS Life Sciences Group Revenue 2024: $0.00
SELLAS Life Sciences Group revenue in 2024 was $0.00.
SELLAS Life Sciences Group Revenue 2023: $0.00
In 2023, SELLAS Life Sciences Group reported revenue of $0.00, plunged 100.0% below 2022.
SELLAS Life Sciences Group Revenue 2022: $1.00M
SELLAS Life Sciences Group revenue in 2022 was $1.00M, plunged 86.8% below 2021.
SELLAS Life Sciences Group Revenue 2021: $7.60M
SELLAS Life Sciences Group revenue in 2021 was $7.60M.
See more financial history for SELLAS Life Sciences Group (SLS).
Sector peers by Revenue
Healthcare peers of SELLAS Life Sciences Group (SLS), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation